Allo-HSCT Compared With Immunosuppressive Therapy for Acquired Aplastic Anemia: A System Review and Meta-Analysis

BMC Immunology - United Kingdom
doi 10.1186/s12865-020-0340-x
Full Text
Abstract

Available in full text

Categories
Immunology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hematopoietic Growth Factors in Aplastic Anemia Patients Treated With Immunosuppressive Therapy-Systematic Review and Meta-Analysis

Haematologica
Hematology
2009English

Costs and Consequences of Immunosuppressive Therapy in Children With Aplastic Anemia

Haematologica
Hematology
2011English

Predicting Response to Immunosuppressive Therapy in Childhood Aplastic Anemia

Haematologica
Hematology
2011English

Association of Human Leukocyte Antigen DRB1*15 and DRB1*15:01 Polymorphisms With Response to Immunosuppressive Therapy in Patients With Aplastic Anemia: A Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

Immunosuppressive Therapy for Aplastic Anemia in Children: A More Severe Disease Predicts Better Survival

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Efficacy and Safety of Immunosuppressive Therapy in the Treatment of Seronegative Hepatitis Associated Aplastic Anemia

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Current Management of Severe Acquired Aplastic Anemia

Einstein (São Paulo, Brazil)
Medicine
2011English

Good Outcome of Haploidentical Hematopoietic SCT as a Salvage Therapy in Children and Adolescents With Acquired Severe Aplastic Anemia

Bone Marrow Transplantation
TransplantationHematology
2014English

603 Acquired Aplastic Anemia: Antibody-Mediated Erythropoietic Failure

Pediatric Research
Child HealthPediatricsPerinatology
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy